| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5fd106eef401088b16d5be97f98a89f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537 |
| filingDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e0047d5ef62d26b802f603b92ed110b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0e9e8e955538cde68f7596dc64fd49d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4609602d18f49acca4d4e76714a09026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4844adc1ed90d8f8d58af8a1c08dc0e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e084eb326c2c6a9a3115a95359b0e12c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf5ec288fda9d1122e442147d2c5004e |
| publicationDate |
2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2383599-T3 |
| titleOfInvention |
Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases |
| abstract |
A pharmaceutical composition for the treatment of cardiovascular or cerebrovascular disease, consisting of: - 5.0% -70.0% Salvia Root extract miltiorrhiza; -10.0% -85.0% of Notoginseng Root extract; -5.0% -70.0% Astragalus Root extract; -1.0% -15.0% Borneol or Dalbergia odorifera Wood oil; and -a pharmaceutically acceptable adjuvant. |
| priorityDate |
2003-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |